🧠 Psychedelic Microdosing Play to Watch MindBio Therapeutics Corp is a clinical stage biotech developing take home microdosing psychedelic therapies for mental health conditions like depression, anxiety, PTSD, and distress in cancer patients. Their lead candidate MB22001 is advancing through Phase 2 clinical development, targeting scalable, regulated psychedelic treatment protocols. Thesis Snapshot: • Positioned in the fast growing psychedelic therapeutics sector • Focus on take home micro dosing mode💊 • Acquisition of AI health monitoring tech to support digital therapeutics integration • 🔬Advancing late stage clinical trials • Massive unmet need in global mental health markets Early positioning in a potentially transformative sector. Mehr sehen